Logo image of UPR.I

UNIPHAR PLC (UPR.I) Stock Fundamental Analysis

DUB:UPR - Euronext Dublin - IE00BJ5FQX74 - Common Stock - Currency: EUR

3  +0.04 (+1.35%)

Fundamental Rating

5

We assign a fundamental rating of 5 out of 10 to UPR. UPR was compared to 24 industry peers in the Health Care Providers & Services industry. UPR scores excellent on profitability, but there are concerns on its financial health. UPR has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

8

1. Profitability

1.1 Basic Checks

UPR had positive earnings in the past year.
UPR had a positive operating cash flow in the past year.
Each year in the past 5 years UPR has been profitable.
In the past 5 years UPR always reported a positive cash flow from operatings.
UPR.I Yearly Net Income VS EBIT VS OCF VS FCFUPR.I Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M

1.2 Ratios

UPR has a better Return On Assets (4.53%) than 83.33% of its industry peers.
UPR has a better Return On Equity (15.98%) than 83.33% of its industry peers.
The Return On Invested Capital of UPR (9.18%) is better than 91.67% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for UPR is above the industry average of 5.60%.
The 3 year average ROIC (9.05%) for UPR is below the current ROIC(9.18%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 4.53%
ROE 15.98%
ROIC 9.18%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
UPR.I Yearly ROA, ROE, ROICUPR.I Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -500 -1K -1.5K

1.3 Margins

With a Profit Margin value of 2.32%, UPR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
UPR's Profit Margin has improved in the last couple of years.
UPR has a Operating Margin (3.06%) which is comparable to the rest of the industry.
UPR's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 15.43%, UPR is doing worse than 62.50% of the companies in the same industry.
UPR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 3.06%
PM (TTM) 2.32%
GM 15.43%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
UPR.I Yearly Profit, Operating, Gross MarginsUPR.I Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

More info and screens

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so UPR is still creating some value.
The number of shares outstanding for UPR remains at a similar level compared to 1 year ago.
Compared to 5 years ago, UPR has about the same amount of shares outstanding.
UPR has a better debt/assets ratio than last year.
UPR.I Yearly Shares OutstandingUPR.I Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M 200M 250M
UPR.I Yearly Total Debt VS Total AssetsUPR.I Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B

2.2 Solvency

An Altman-Z score of 2.74 indicates that UPR is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of UPR (2.74) is better than 83.33% of its industry peers.
UPR has a debt to FCF ratio of 18.31. This is a negative value and a sign of low solvency as UPR would need 18.31 years to pay back of all of its debts.
UPR's Debt to FCF ratio of 18.31 is on the low side compared to the rest of the industry. UPR is outperformed by 75.00% of its industry peers.
A Debt/Equity ratio of 0.93 indicates that UPR is somewhat dependend on debt financing.
The Debt to Equity ratio of UPR (0.93) is comparable to the rest of the industry.
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 18.31
Altman-Z 2.74
ROIC/WACC1.27
WACC7.23%
UPR.I Yearly LT Debt VS Equity VS FCFUPR.I Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M 300M 400M

2.3 Liquidity

A Current Ratio of 0.88 indicates that UPR may have some problems paying its short term obligations.
With a Current ratio value of 0.88, UPR perfoms like the industry average, outperforming 50.00% of the companies in the same industry.
UPR has a Quick Ratio of 0.88. This is a bad value and indicates that UPR is not financially healthy enough and could expect problems in meeting its short term obligations.
UPR's Quick ratio of 0.56 is on the low side compared to the rest of the industry. UPR is outperformed by 62.50% of its industry peers.
Industry RankSector Rank
Current Ratio 0.88
Quick Ratio 0.56
UPR.I Yearly Current Assets VS Current LiabilitesUPR.I Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

More info and screens

6

3. Growth

3.1 Past

UPR shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 43.33%, which is quite impressive.
Measured over the past years, UPR shows a quite strong growth in Earnings Per Share. The EPS has been growing by 15.47% on average per year.
Looking at the last year, UPR shows a quite strong growth in Revenue. The Revenue has grown by 8.51% in the last year.
Measured over the past years, UPR shows a quite strong growth in Revenue. The Revenue has been growing by 10.72% on average per year.
EPS 1Y (TTM)43.33%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%13.76%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%6.8%

3.2 Future

Based on estimates for the next years, UPR will show a quite strong growth in Earnings Per Share. The EPS will grow by 19.49% on average per year.
The Revenue is expected to grow by 2.31% on average over the next years.
EPS Next Y10.11%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
EPS Next 5Y19.49%
Revenue Next Year4.99%
Revenue Next 2Y5.13%
Revenue Next 3Y4.87%
Revenue Next 5Y2.31%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
UPR.I Yearly Revenue VS EstimatesUPR.I Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 1B 2B 3B
UPR.I Yearly EPS VS EstimatesUPR.I Yearly EPS VS EstimatesYearly EPS VS Estimates 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 0.2 0.4 0.6

More info and screens

5

4. Valuation

4.1 Price/Earnings Ratio

UPR is valuated correctly with a Price/Earnings ratio of 12.50.
Based on the Price/Earnings ratio, UPR is valued a bit cheaper than the industry average as 79.17% of the companies are valued more expensively.
Compared to an average S&P500 Price/Earnings ratio of 28.18, UPR is valued rather cheaply.
The Price/Forward Earnings ratio is 13.26, which indicates a correct valuation of UPR.
Based on the Price/Forward Earnings ratio, UPR is valued a bit cheaper than 66.67% of the companies in the same industry.
UPR is valuated rather cheaply when we compare the Price/Forward Earnings ratio to 20.81, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 12.5
Fwd PE 13.26
UPR.I Price Earnings VS Forward Price EarningsUPR.I Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

UPR's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of UPR indicates a slightly more expensive valuation: UPR is more expensive than 70.83% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 35.11
EV/EBITDA 9.01
UPR.I Per share dataUPR.I EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
The excellent profitability rating of UPR may justify a higher PE ratio.
PEG (NY)1.24
PEG (5Y)0.81
EPS Next 2Y8.96%
EPS Next 3Y9.35%

More info and screens

3

5. Dividend

5.1 Amount

UPR has a yearly dividend return of 0.87%, which is pretty low.
Compared to an average industry Dividend Yield of 2.73, UPR has a dividend in line with its industry peers.
With a Dividend Yield of 0.87, UPR pays less dividend than the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 0.87%

5.2 History

The dividend of UPR is nicely growing with an annual growth rate of 33.58%!
Dividend Growth(5Y)33.58%
Div Incr Years2
Div Non Decr Years2
UPR.I Yearly Dividends per shareUPR.I Yearly Dividends per shareYearly Dividends per share 2020 2021 2022 2023 2024 2025 0.01 0.01 0.02 0.02 0.03

5.3 Sustainability

UPR pays out 7.91% of its income as dividend. This is a sustainable payout ratio.
UPR's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP7.91%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
UPR.I Yearly Income VS Free CF VS DividendUPR.I Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M 40M 60M 80M 100M
UPR.I Dividend Payout.UPR.I Dividend Payout, showing the Payout Ratio.UPR.I Dividend Payout.PayoutRetained Earnings

More info and screens

UNIPHAR PLC

DUB:UPR (5/2/2025, 7:00:00 PM)

3

+0.04 (+1.35%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2025-02-25/bmo
Earnings (Next)09-01 2025-09-01
Inst Owners44.92%
Inst Owner ChangeN/A
Ins Owners5.43%
Ins Owner ChangeN/A
Market Cap778.71M
Analysts82
Price Target4.61 (53.67%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 0.87%
Yearly Dividend0.02
Dividend Growth(5Y)33.58%
DP7.91%
Div Incr Years2
Div Non Decr Years2
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-0.42%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.42%
Valuation
Industry RankSector Rank
PE 12.5
Fwd PE 13.26
P/S 0.28
P/FCF 35.11
P/OCF 6.27
P/B 1.94
P/tB N/A
EV/EBITDA 9.01
EPS(TTM)0.24
EY8%
EPS(NY)0.23
Fwd EY7.54%
FCF(TTM)0.09
FCFY2.85%
OCF(TTM)0.48
OCFY15.96%
SpS10.67
BVpS1.55
TBVpS-0.64
PEG (NY)1.24
PEG (5Y)0.81
Profitability
Industry RankSector Rank
ROA 4.53%
ROE 15.98%
ROCE 10.78%
ROIC 9.18%
ROICexc 10.57%
ROICexgc 62.78%
OM 3.06%
PM (TTM) 2.32%
GM 15.43%
FCFM 0.8%
ROA(3y)4.04%
ROA(5y)4.1%
ROE(3y)15.06%
ROE(5y)15.61%
ROIC(3y)9.05%
ROIC(5y)8.82%
ROICexc(3y)10.45%
ROICexc(5y)10.56%
ROICexgc(3y)82.98%
ROICexgc(5y)N/A
ROCE(3y)10.62%
ROCE(5y)10.36%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y-4.71%
ROICexc growth 5Y-1.65%
OM growth 3Y-0.1%
OM growth 5Y4.8%
PM growth 3Y-2.16%
PM growth 5Y12.91%
GM growth 3Y3%
GM growth 5Y7.31%
F-Score6
Asset Turnover1.96
Health
Industry RankSector Rank
Debt/Equity 0.93
Debt/FCF 18.31
Debt/EBITDA 3.12
Cap/Depr 288.68%
Cap/Sales 3.68%
Interest Coverage 2.89
Cash Conversion 103.55%
Profit Quality 34.55%
Current Ratio 0.88
Quick Ratio 0.56
Altman-Z 2.74
F-Score6
WACC7.23%
ROIC/WACC1.27
Cap/Depr(3y)149.63%
Cap/Depr(5y)116.24%
Cap/Sales(3y)1.97%
Cap/Sales(5y)1.5%
Profit Quality(3y)72.81%
Profit Quality(5y)95.5%
High Growth Momentum
Growth
EPS 1Y (TTM)43.33%
EPS 3Y9.69%
EPS 5Y15.47%
EPS Q2Q%13.76%
EPS Next Y10.11%
EPS Next 2Y8.96%
EPS Next 3Y9.35%
EPS Next 5Y19.49%
Revenue 1Y (TTM)8.51%
Revenue growth 3Y12.55%
Revenue growth 5Y10.72%
Sales Q2Q%6.8%
Revenue Next Year4.99%
Revenue Next 2Y5.13%
Revenue Next 3Y4.87%
Revenue Next 5Y2.31%
EBIT growth 1Y9.42%
EBIT growth 3Y12.44%
EBIT growth 5Y16.03%
EBIT Next Year49.95%
EBIT Next 3Y20.25%
EBIT Next 5Y12.87%
FCF growth 1Y7.9%
FCF growth 3Y-16.24%
FCF growth 5Y-26.09%
OCF growth 1Y136.65%
OCF growth 3Y33.54%
OCF growth 5Y3.04%